SLC22A1 and metabolic dysfunction-associated steatotic liver disease: In conclusion, changing the membrane free cholesterol content alters the function and localization of both NTCP and OCT1, suggesting that individuals with liver conditions like NAFLD and NASH have impaired transporter capacities.